Louis Calvarin - Innophos Holdings Insider

IPHS -- USA Stock  

USD 45.74  0.11  0.24%

Dr. Louis Calvarin is the Vice President, Strategy and Chief Risk Officer of Innophos Holdings Inc. Prior to which he was the Vice President Operations of Innophos Holdings Inc. Dr. Calvarin joined Rhodia in France in 1986. He was Director of Manufacturing and Engineering for Specialty Phosphates since January 2004. Prior to that, Dr. Calvarin held the positions of Director of Manufacturing for Specialty Phosphates, Mineral Chemicals Industrial Operations Manager for Home, Personal Care and Industrial Ingredients, and Projects Director for Paint, Paper and Construction Materials
Age: 50  SVP Since 2014  Ph.D    
609-495-2495  http://www.innophos.com
Calvarin earned a Ph.D. degree in Chemical Engineering from the Ecole Nationale Superieure des Mines in France and graduated from Ecole Polytechnique in France.

Louis Calvarin Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.78 % which means that it generated profit of $6.78 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 6.55 % meaning that it created $6.55 on every $100 dollars invested by stockholders.
The company currently holds 345.01 M in liabilities with Debt to Equity (D/E) ratio of 102.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has Current Ratio of 3.16 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 9 records

SVP Since

Elizabeth AlbrightThe Chemours Company
Patrick TrippelH B Fuller Company
Brian BerubeCabot Corporation
Matthew JuneauAlbemarle Corporation
Traci JensenH B Fuller Company
Karen NarwoldAlbemarle Corporation
Steven KennyH B Fuller Company
Francisco FortanetInternational Flavors Fragrance
Richard OLearyInternational Flavors Fragrance

Entity Summary

Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. Innophos Holdings, Inc. was founded in 2004 and is headquartered in Cranbury, New Jersey. Innophos Holdings operates under Specialty Chemicals classification in USA and traded on NASDAQ. It employs 1373 people.Innophos Holdings (IPHS) is traded on BATS Exchange in USA. It is located in NEW JERSEY U.S.A and employs 1,373 people. Innophos Holdings is listed under Wholesale category by Fama And French industry classification.

Innophos Holdings Leadership Team

Randolph Gress, Chairman, CEO and Pres
Eugenia Erlij, Vice President - Marketing
Kim Mink, CEO and President and Director
Abraham Shabot, Vice President Director General, Innophos Latin America
James Zallie, Independent Director
Peter Thomas, Director
Jean Mainente, Chief Human Resource Officer, Senior Vice President
Amado Cavazos, Independent Director
Nicolas Meyrial, Vice President - Commercial Nutrition
William Farran, Sr. VP, General Counsel and Member of Proxy Committee
Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development
Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis
Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S
Gary Cappeline, Lead Independent Director
Susan Turner, Vice President - Quality & Regulatory
Yasef Murat, Senior Vice President - Global Manufacturing
Hermanus Kieftenbeld, CFO, Senior Vice President
Linda Myrick, Independent Director
Amy Hartzell, Vice President - Supply Chain and Purchasing
Sherry Duff, Chief Marketing Officer, Vice President
Gail Holler, Vice President - Human Resources
Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary
Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy
Robert Sklans, Chief Human Resource Officer, Senior Vice President
Joseph Golowski, Sr. VP of Global Specialty Phosphates
Charles Brodheim, Vice President Corporate Controller
Karen Osar, Independent Director
John Steitz, Independent Director
Robert Zatta, Director

Stock Performance Indicators

Did you try this?

Run Fund Screener Now


Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Fund Screener

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com